Old Mission Capital’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.83M Buy
+165,224
New +$4.55M 0.08% 138
2025
Q4
– Sell
-81,764
Closed -$2.42M – 1058
2025
Q3
$2.42M Buy
81,764
+4,507
+6% +$110K 0.05% 216
2025
Q2
$1.19M Buy
77,257
+48,809
+172% +$790K 0.02% 389
2025
Q1
$481K Sell
28,448
-5,197
-15% -$107K 0.01% 627
2024
Q4
$828K Buy
33,645
+21,219
+171% +$926K 0.01% 451
2024
Q3
$670K Buy
12,426
+4,721
+61% +$253K 0.01% 641
2024
Q2
$413K Sell
7,705
-2,295
-23% -$142K 0.01% 806
2024
Q1
$692K Buy
10,000
+4,063
+68% +$239K 0.01% 629
2023
Q4
$304K Buy
5,937
+3,543
+148% +$174K 0.01% 945
2023
Q3
$138K Sell
2,394
-139
-5% -$7.18K ﹤0.01% 1088
2023
Q2
$112K Buy
2,533
+421
+20% +$19.7K ﹤0.01% 1068
2023
Q1
$107K Sell
2,112
-12,894
-86% -$762K ﹤0.01% 1255
2022
Q4
$917K Buy
+15,006
New +$1.16M 0.03% 527

Other funds holding CNBS

Old Mission Capital's CNBS Position: Q2 2026 in Review

Old Mission Capital opened a new position in Amplify Seymour Cannabis ETF (CNBS) in Q2 2026: 165,224 shares worth $4.83M. The stake represents 0.08% of the portfolio and ranks #138 among its holdings. This is a return to the name: Old Mission Capital previously reported a position in CNBS as recently as Q3 2025.

Old Mission Capital first reported a position in CNBS in Q4 2022 and has held it in 13 quarters since. 16 funds tracked by Wall St. Rank hold CNBS as of Q2 2026.

  • Old Mission Capital held 165,224 shares of Amplify Seymour Cannabis ETF worth $4.83M as of Q2 2026.
  • Amplify Seymour Cannabis ETF was a new Old Mission Capital position in Q2 2026.
  • Amplify Seymour Cannabis ETF made up 0.08% of Old Mission Capital's portfolio in Q2 2026, its #138 holding.
  • Old Mission Capital first reported a position in Amplify Seymour Cannabis ETF in Q4 2022 and has held it in 13 quarters since.
  • 16 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q2 2026.

Based on Old Mission Capital's 13F filing for Q2 2026, filed 14 Aug 2026.